<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:55:40Z</responseDate>
  <request identifier="oai:figshare.com:article/32805299" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32805299</identifier>
        <datestamp>2026-10-01T16:16:44Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Understanding the cognitive and psychosocial impact of anti-NMDA receptor encephalitis</dc:title>
          <dc:creator>Laura Burke (106805)</dc:creator>
          <dc:subject>PUREID: 671086919</dc:subject>
          <dc:subject>Anti-N-Methyl-D-Aspartate Receptor Encephalitis</dc:subject>
          <dc:subject>patient reported outcome measures</dc:subject>
          <dc:subject>quality of Life</dc:subject>
          <dc:subject>psychological well-being</dc:subject>
          <dc:subject>neuropsychology</dc:subject>
          <dc:subject>cognitive ability</dc:subject>
          <dc:description>&lt;p&gt;This thesis aims to contribute to the growing evidence base examining the long-term cognitive and psychosocial outcomes of anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDARE). Despite increasing recognition of the condition, understanding of long-term neurocognitive outcomes following diagnosis remains variable across existing studies. In addition, the long-term impact of anti-NMDARE on psychological wellbeing, quality of life (QOL), and everyday functioning is poorly understood.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;The first paper comprised a scoping review that mapped existing evidence on patient-reported QOL and psychological functioning (i.e. anxiety and depression), alongside an appraisal of methodological quality. The second paper presented a cross-sectional case series employing a convergent parallel mixed methods design. Five participants with a confirmed diagnosis completed a series of cognitive tasks and psychosocial outcome measures, alongside a semi-structured interview which explored the challenges faced and supports required post-diagnosis.&lt;/p&gt;&lt;br&gt;&lt;i&gt;Thesis is embargoed until 31 July 2029.&lt;/i&gt;&lt;br&gt;</dc:description>
          <dc:date>2026-10-01T16:16:44Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32805299.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Understanding_the_cognitive_and_psychosocial_impact_of_anti-NMDA_receptor_encephalitis/32805299</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2029-07-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
